Michael Cole is part of Bank of Ann Arbor’s Technology Industry Group. In this guest blog post, he shares why a capital call line of credit can give venture firms predictable cash flow and investing agility featuring commentary from MVCA members Renaissance Venture Capital Fund, Arboretum Ventures and Augment Ventures. Bank of Ann Arbor is a […]
More than jobs were at stake for pharmaceutical scientists facing the closure of Pfizer Michigan Research & Development in Ann Arbor. The 2007 closure also created the potential to lose decades of drug development experience, including critical specialties that were in high demand from small and mid-size bio-tech and pharmaceutical clients. Former co-workers Gerry Cox […]